多灶性肝细胞癌肝内微生物异质性及其与宿主基因组和转录组改变的关系
本研究对58例多灶性肝细胞癌患者的242个肿瘤结节和58个癌旁非肿瘤组织进行多组学分析,揭示肝内微生物群落在多灶性肝细胞癌中的异质性,并通过染色和电镜确认肿瘤结节内存在细菌。突变谱分析将患者分为肝内转移(IM)型和多中心发生(MO)型,两组结节细菌群落存在差异(P=0.01),九种细菌标志物组合区分IM与MO结节的AUROC为0.795。IM结节中上皮-间质转化通路上调并与IM富集细菌相关,粪肠球菌和咽峡炎链球菌等IM富集细菌通过诱导免疫抑制微环境和上皮-间质转化促进HCC细胞迁移、侵袭和肿瘤进展。
要点
- 多灶性肝细胞癌不同结节的肝内微生物群落存在异质性。
- 九种细菌标志物组合区分IM与MO结节的AUROC为0.795。
- IM富集细菌如粪肠球菌和咽峡炎链球菌可促进HCC进展。
核心结论
- 肝内微生物组参与多灶性肝细胞癌的异质性和发病机制。
研究设计与样本
- 对58例多灶性肝细胞癌患者的242个肿瘤结节和58个癌旁非肿瘤组织进行多组学分析。
- 通过革兰染色、脂多糖染色、脂磷壁酸染色和透射电镜确认HCC结节内存在细菌。
- 通过突变谱分析将患者分为肝内转移(IM)型和多中心发生(MO)型。
主要发现
- IM与MO结节的细菌群落存在差异(P=0.01)。
- 九种细菌标志物组合区分IM与MO结节的AUROC为0.795。
- IM结节中上皮-间质转化通路上调并与IM富集细菌相关。
- 粪肠球菌和咽峡炎链球菌等IM富集细菌在原位HCC小鼠模型中通过诱导免疫抑制微环境和上皮-间质转化促进HCC细胞迁移、侵袭和肿瘤进展。
关键数值与推荐
- IM与MO结节细菌群落差异的P=0.01。
- 九种细菌标志物组合区分IM与MO结节的AUROC为0.795。
临床怎么用
- 作者认为细菌异质性应作为多灶性肝细胞癌治疗的生物标志物和干预靶点。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: The signature of the intrahepatic microbiome in multifocal hepatocellular carcinoma (HCC) and its association with genomic alterations remain elusive. In this study, we performed multiomics profiling of 242 HCC tumor nodules and 58 adjacent nontumor tissues from 58 patients with multifocal HCC, revealing heterogeneous microbial communities in multifocal HCC. The presence of bacteria in HCC nodules was confirmed by Gram stain, lipopolysaccharide, lipoteichoic acid staining, and transmission electron microscopy. Mutational profiling stratified patients into intrahepatic metastasis (IM)-HCC and multicentric occurrence (MO)-HCC. Bacterial communities differed between IM and MO nodules (P = 0.01). A nine-bacterium biomarker panel could distinguish IM nodules from MO nodules with an AUROC of 0.795. The epithelial-mesenchymal transition pathway was upregulated in IM nodules and correlated with IM-enriched bacteria. IM-enriched bacteria such as Enterococcus faecalis and Streptococcus anginosus promoted HCC cell migration, invasion, and tumor progression in orthotopic HCC mouse models by inducing an immunosuppressive microenvironment and epithelial-mesenchymal transition. Collectively, the intrahepatic microbiome contributes to the heterogeneity and pathogenesis of multifocal HCC. SIGNIFICANCE: We reveal intraindividual heterogeneous microbial communities among nodules from patients with multifocal HCC. IM-HCC-enriched bacteria promote tumor growth and influence the tumor microenvironment of HCC. Our work highlights the necessity of considering bacterial heterogeneity as biomarkers and targets for multifocal HCC therapeutic intervention. See related commentary by Dzutsev and Trinchieri, p. 1540.
引用
- Lu Y, Xu L, Chen W, et al. Intrahepatic Microbial Heterogeneity in Multifocal Hepatocellular Carcinoma and Its Association with Host Genomic and Transcriptomic Alterations. Cancer Discov. 2025. PMID: 40287964. doi:10.1158/2159-8290.CD-24-1259
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。